Berapa harga Novo Nordisk A/S (NOVO-B)

Harga Novo Nordisk A/S (NOVO-B) adalah $43.92

Apa kapitalisasi pasar Novo Nordisk A/S (NOVO-B)

Kapitalisasi pasar Novo Nordisk A/S (NOVO-B) adalah $195.10B

Novo Nordisk A/S (NOVO-B) Pemecahan Saham

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Tahun	Pemecahan	Kelipatan	Kelipatan Kumulatif
2023-09-13	2:1	x2	x20
2014-01-02	5:1	x5	x10
2008-01-25	2:1	x2	x2

Tahun

Pemecahan

Kelipatan

Kelipatan Kumulatif

2023-09-13

2:1

x20

2014-01-02

5:1

x10

2008-01-25

2:1

Perusahaan	Jumlah pemecahan saham	Kelipatan Kumulatif	Negara
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Perusahaan

Jumlah pemecahan saham

Kelipatan Kumulatif

Negara